Alpha-1-acid glycoprotein 1 Recombinant Antibody

$Blocking buffer: 5% NFDM\/TBST\r\nPrimary ab dilution: 1:1000\r\nPrimary ab incubation condition: 2 hours at room temperature\r\nLysate: Human serum\r\nProtein loading quantity: 20 \u03bcg\r\nExposure time: 60 s\r\nPredicted MW: 24 kDa\r\nObserved MW: 45 kDa\r\n$

Blocking buffer: 5% NFDM\/TBST\r\nPrimary ab dilution: 1:1000\r\nPrimary ab incubation condition: 2 hours at room temperature\r\nLysate: Human serum\r\nProtein loading quantity: 20 \u03bcg\r\nExposure time: 60 s\r\nPredicted MW: 24 kDa\r\nObserved MW: 45 kDa\r\n

Applications

Reactivity

Human

Overview
Catalog #	bsm-60270m
Product Name	Alpha-1-acid glycoprotein 1 Recombinant Antibody
Applications	WB
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Mouse
Source	KLH conjugated synthetic peptide derived from human Alpha-1-acid glycoprotein 1
Clonality	Recombinant
Isotype	IgG2a/Kappa
Concentration	1mg/ml
Purification	Purified by Protein G.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	5004
Swiss Prot	P02763
Subcellular location	Secreted
Synonyms	A1AG1_HUMAN; AGP 1; AGP A; AGP; Alpha 1 acid glycoprotein; Alpha 1-Acid Glycoprotein; Alpha-1 acid glycoprotein; OMD 1; ORM; ORM1; Orosomucoid 1; Orosomucoid-1.
Background	This gene encodes a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined; however, it may be involved in aspects of immunosuppression. [provided by RefSeq, Jul 2008]
Application Dilution
WB	=1:500-2000